Genprex, Inc. Stockholders Equity

Quick Answer

Genprex, Inc. reported Stockholders Equity of $7.96 million for fiscal year 2025.

Genprex, Inc. Stockholders Equity — Annual History

Fiscal Year Stockholders Equity YoY Change
2025 $7.96M +391.4%
2024 $1.62M -78.2%
2023 $7.42M -66.7%
2022 $22.27M -19.0%
2022 $27.49M -15.2%
2022 $32.41M -12.5%
2022 $37.02M -10.3%
2021 $41.28M +33.5%
2020 $30.92M +922.5%
2019 $3.02M -66.0%
2018 $8.88M +1972.3%
2017 $428.6K -73.6%
2016 $1.62M +312.7%
2015 $393.7K

Quarterly Stockholders Equity

Quarter Ending Stockholders Equity YoY QoQ
September 30, 2025 $767.8K -53.9% -44.8%
June 30, 2025 $1.39M -68.0% -64.0%
March 31, 2025 $3.87M -55.8% +138.7%
December 31, 2024 $1.62M -78.2% -2.7%
September 30, 2024 $1.66M -86.5% -61.7%
June 30, 2024 $4.35M -63.9% -50.4%
March 31, 2024 $8.76M -52.6% +18.1%
December 31, 2023 $7.42M -66.7% -39.7%
  • Genprex, Inc. showed an increase of +391.4% in Stockholders Equity compared to the prior fiscal year.
  • Over the 2015–2025 period, Genprex, Inc.’s stockholders equity has grown by 1922.1% (from $393.7 thousand to $7.96 million).
  • The most recent figure is from Genprex, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment